You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 163 No. 7, July 2009 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Special Feature
 •Online Features
 This Article
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Pediatrics
 •Pediatrics, Other
 •Hemangiomas
 •Diagnosis
 •Vascular Malformations
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Picture of the Month—Diagnosis


Arch Pediatr Adolesc Med. 2009;163(7):665.

Denouement and Discussion: Klippel-Trénaunay Syndrome



Klippel-Trénaunay syndrome (KTS) is a rare disorder characterized by the triad of port-wine stain, hypertrophy of bone and soft tissue, and varicose veins or venous malformations. The syndrome was described in 1900 by French physicians Klippel and Trénaunay.1 In 1907, Weber2 noted similar findings in association with arteriovenous malformations.

The diagnosis of KTS can be made when any 2 of the 3 features are present. Jacob et al,3 in a study of 253 patients with KTS, observed that 63% of the patients had all 3 features and that 37% had 2 of the 3 features. Port-wine stain has been observed in 98% of patients, varicosities or venous malformation in 72%, and limb hypertrophy in 67%.

The exact cause of KTS is unknown, although several theories exist. Most cases are sporadic, and a few cases could be of autosomal dominant inheritance. A new theory of paradominant inheritance was suggested in a study of monozygotic twins.4 A novel mutation in the RASA1 gene (OMIM139150) was found in KTS.5

No racial or sex predilection for KTS has been documented. The syndrome is present at birth or develops during early childhood and generally affects a single extremity. The lower extremity is the most commonly affected site (95% of patients), followed by the arms and the trunk.

The most common manifestation is capillary hemangioma or port-wine stain. Usually the hemangioma has a distinct border that follows the midline and is generally noted on the lateral aspect of the limb. Typically, the capillary vascular malformation does not progress or it regresses with time. The hemangioma can have cutaneous or deep involvement (osseous and muscular). Visceral organs such as spleen, bladder, liver, pleura, and gastrointestinal tract may also be affected.6 Involvement of the gastrointestinal tract has been described in 20% of patients; bleeding of the distal colon and rectum is the most common symptom. Genitourinary involvement (hematuria) also may be noted in KTS.

Varicosities or venous malformations often spare the saphenous distribution, sometimes in the pelvic region. Varicose veins can be superficial, deep, or perforating. Venous stasis results from valvular insufficiency, obstructed venous outflow, or abnormal lymphatic drainage.

Bony and soft-tissue hypertrophy is another feature of KTS; increased length and circumference of the affected extremity are typical. Hypertrophy may be present at birth and progresses with time. Complications of KTS include stasis, bleeding, ulcerations, dermatitis, cellulitis, thrombophlebitis, pulmonary emboli, and abnormalities of the vertebral column.

The diagnosis of KTS is made on the basis of clinical history and findings at physical examination. Typical hemangioma associated with bony and soft-tissue hypertrophy or abnormal venous structure is sufficient for the diagnosis. A skin biopsy specimen of the hemangioma is unnecessary for the diagnosis.

If complications are present or suspected (eg, deep venous thrombosis), imaging studies such as color Doppler ultrasonography and magnetic resonance imaging can be useful. Radiographic examination can be used to define bony hypertrophy and to measure the difference in the length of the affected extremity. Imaging studies of the abdomen are required to rule out a vascular malformation in the perineum or abdomen.7 The most common differential diagnoses are Parkes Weber syndrome and proteus syndrome.

Medical treatment of KTS is conservative and symptomatic. Some patients with KTS have severe pain in the affected limb.8 A multidisciplinary approach is necessary when complications are present. Compression garments are required to treat chronic venous insufficiency and lymphedema. Cellulitis and thrombophlebitis are treated with elevation, compression, and analgesic and antibiotic therapy. Skin hygiene is useful in preventing cellulitis. In women with KTS, it is recommended that, to prevent deep venous thrombosis, estrogen-containing contraceptives not be used.

In addition to medical treatment, if limb discrepancies are present, surgical orthopedic procedures may be considered to prevent functional and psychologic disabilities; laser treatment of the skin lesions could be useful in treating the superficial component of the hemangioma to improve its color. Surgical treatment of varicosities is controversial. Yearly clinical follow-up of patients with KTS is recommended, with more frequent follow-up if clinically indicated.

Insofar as long-term outcome, hypertrophy of the limb is the most common problem, often impairing function and affecting mobility. All children with KTS must be monitored for growth abnormalities. An important issue is pain, which can worsen and seriously affect quality of life8 and requires psychologic support. When the limb is grossly enlarged, amputation may rarely be required.9

Return to Quiz Case.


AUTHOR INFORMATION

Correspondence: Andrea E. Scaramuzza, MD, Department of Pediatrics, Azienda Ospedaliera, "Ospedale Luigi Sacco," University of Milan, Via G. B. Grassi 74, 20154 Milan, Italy (scaramuzza.andrea{at}hsacco.it).

Accepted for Publication: October 21, 2008.

Author Contributions: Dr Scaramuzza had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Mameli, Scaramuzza, Riboni, De Palma, and Zuccotti. Acquisition of data: Mameli and Tadini. Analysis and interpretation of data: Mameli, Scaramuzza, Tadini, and Riboni. Drafting of the manuscript: Mameli and Scaramuzza. Critical revision of the manuscript for important intellectual content: Scaramuzza, Tadini, Riboni, De Palma, and Zuccotti. Administrative, technical, and material support: Mameli, Scaramuzza, Tadini, Riboni, De Palma, and Zuccotti. Study supervision: Mameli.

Financial Disclosure: None reported.


REFERENCES

1. Klippel M, Trénaunay P. Du naevus variquex osteohypertrophique. Arch Gen Med. 1900;3:641-672.
2. Weber FP. Angioma-formation in connection with hypertrophy of limbs and hemi-hypertrophy. Br J Dermatol. 1907;19:231. WEB OF SCIENCE
3. Jacob AG, Driscoll DJ, Shaughnessy WJ, Stanson AW, Clay RP, Gloviczki P. Klippel-Trénaunay syndrome: spectrum and management. Mayo Clin Proc. 1998;73(1):28-36. FREE FULL TEXT
4. Hofer T, Frank J, Itin PH. Klippel-Trénaunay syndrome in a monozygotic male twin. Eur J Dermatol. 2005;15(5):341-343. WEB OF SCIENCE | PUBMED
5. Hershkovitz D, Bercovich D, Sprecher E, Lapidot M. RASA1 mutations may cause hereditary capillary malformations without arteriovenous malformations. Br J Dermatol. 2008;158(5):1035-1040. FULL TEXT | WEB OF SCIENCE | PUBMED
6. Cha SH, Romeo MA, Neutze JA. Visceral manifestations of Klippel-Trénaunay syndrome. Radiographics. 2005;25(6):1694-1697. FREE FULL TEXT
7. Elsayes KM, Menias CO, Dillman JR, Platt JF, Willatt JM, Heiken JP. Vascular malformation and hemangiomatosis syndromes: spectrum of imaging manifestations. AJR Am J Roentgenol. 2008;190(5):1291-1299. FREE FULL TEXT
8. Lee A, Driscoll D, Gloviczki P, Clay R, Shaughnessy W, Stans A. Evaluation and management of pain in patients with Klippel-Trénaunay syndrome: a review. Pediatrics. 2005;115(3):744-749. FREE FULL TEXT
9. Pawel BR, Spencer K, Dormans J. Klippel-Trénaunay syndrome. Arch Dis Child. 2005;90(11):1127. FREE FULL TEXT

SECTION EDITOR: SAMIR S. SHAH, MD, MSCE



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Picture of the Month—Quiz Case
Chiara Mameli, Andrea E. Scaramuzza, Gian Luca Tadini, Sara Riboni, Alessandra De Palma, and Gian Vincenzo Zuccotti
Arch Pediatr Adolesc Med. 2009;163(7):664.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.